Invectys publishes positive clinical results for its INVAC-1 Phase I Study in Clinical Cancer Research With an extended Phase I and a new delivery method…
A DNA vaccine targeting a specific cancer marker Cancer cells produce an enzyme which is key to their unlimited proliferation, but is nearly never expressed in normal…
Medicen Paris Region et Invectys annoncent le succès du projet TelVac pour la recherche d’un candidat vaccin contre le cancer…
